LifeCodexx Completes Recruitment for Clinical Trial of Trisomy 21 Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GATC Biotech subsidiary LifeCodexx said today that it has completed the recruitment of more than 500 blood samples for a clinical study of its non-invasive prenatal diagnostic test for trisomy 21.

The Konstanz, Germany-based company said that the prospective and blinded study will evaluate its sequencing-based PraenaTest against "conventional invasive methods."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.